| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 42 |
| 1 | BICALUTAMIDE | 29 |
| 2 | FUROSEMIDE | 15 |
| 3 | ETANERCEPT | 12 |
| 4 | ADALIMUMAB | 11 |
| 5 | TESTOSTERONE | 11 |
| 6 | GOSERELIN | 10 |
| 7 | VALSARTAN | 9 |
| 8 | ANASTROZOLE | 8 |
| 9 | ATORVASTATIN CALCIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BICALUTAMIDE | 29 | 0.0019 |
| 1 | TESTOSTERONE ENANTHATE | 3 | 0.0018 |
| 2 | PINDOLOL | 1 | 0.0012 |
| 3 | AMILORIDE HYDROCHLORIDE | 1 | 0.0012 |
| 4 | FLUTAMIDE | 1 | 0.0010 |
| 5 | DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE | 1 | 0.0010 |
| 6 | GOSERELIN | 10 | 0.0007 |
| 7 | GINKGO BILOBA | 1 | 0.0007 |
| 8 | FINASTERIDE | 42 | 0.0007 |
| 9 | CEFACLOR | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | 5-alpha Reductase Inhibitor [EPC] | 48 |
| 1 | Androgen Receptor Inhibitor [EPC] | 30 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 3 | Loop Diuretic [EPC] | 15 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 14 |
| 6 | Aromatase Inhibitor [EPC] | 13 |
| 7 | Corticosteroid [EPC] | 13 |
| 8 | Interleukin-23 Antagonist [EPC] | 12 |
| 9 | Androgen [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 48 | 0.0005 |
| 2 | Androgen Receptor Inhibitor [EPC] | 30 | 0.0004 |
| 3 | Androgen [EPC] | 11 | 0.0004 |
| 4 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 6 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 8 | Interleukin-23 Antagonist [EPC] | 12 | 0.0001 |
| 9 | Aromatase Inhibitor [EPC] | 13 | 0.0001 |